Gravar-mail: An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol(®)) on Glycaemic Responses in Healthy Participants